Data Foundry

Drug recalls 2026

Tirzepatide/Niacinamide 2mL vial — Class II drug recall D-0040-2027

Ongoing recall by Houston Rx LLC, reported 2026-10-21, distributed nationwide. Lack of assurance of sterility.

Recall numberD-0040-2027
Product typeDrug
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmHouston Rx LLC, Houston, TX, United States
Recall initiated2026-09-25
Classified2026-10-13
Reported by FDA2026-10-21
DistributedNationwide (US)
Quantity64 vials
Reason classessterility
Lot numbersTZN-080326-20/2-2
Expiration dates2026-12-01

Product

Tirzepatide/Niacinamide 2mL vial (40 MG per Vial) Inj 20mg/2mg/mL, RX Only, Houston RX LLC, 15430 Vantage Parkway E STE 220, Houston, TX 77032.

Reason for recall

Lack of assurance of sterility.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0040-2027. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-10-27. Not affiliated with or endorsed by FDA. Not medical or legal advice.